Everything you wanted to know
" Have you got asthma?"

EAACI Portal

Eaaci: European Academy of Allergy and Clinical Immunology



  • Find EAACI in Social Media

    Want to keep up to date with all EAACI news and deadlines?
    Why not follow us on Twitter and Instagram, like our page on Facebook or find us on LinkedIn and Google Plus? You can also post your photos from EAACI events as well as your views and opinions on a range of topics
  • Innovative treatments to control and identify severe asthma

    Athens, Greece. 13 November 2014

    Two new studies on the treatment and identification of severe asthma may have found new ways to control and identify this disease. Read more in the Press Release here, also available in SP, GR, DE, FR and IT.
  • Reducing the incidence of food allergy in children

    Dublin, Ireland, 9 October 2014

    The frequency of food allergic reactions is greater among children than among adults and up to 17% of the European population may be affected. During FAAM 2014 that took place in October, in Dublin two new studies focusing on the prevention of allergy in children were presented. Read more in the Press Release here, also available in Spanish.
  • Faster and accurate identification of drugs causing allergic reactions: a great relief for patients

    Krakow (Poland), 18 September 2014

    Cutaneous adverse drug reactions: Diagnosis of CADR could now improve significantly thanks to a new method developed by a group of researchers led by Dr Grzegorz Porebski, Jagiellonian University, Department of Clinical and Environmental Allergology (Krakow, Poland). Read more in the Press Release here.

  • Up to 22% of European children have an allergy, with serious reaction to food on the rise

    Zurich, Switzerland 07.04.2014

    – Anaphylaxis is increasingly found in allergic reactions in children, primarily caused by food allergies in this population group: up to 22% of European children have an allergy, with serious reaction to food on the rise1. The severity of its effects, which can be fatal, demands the attention not only of allergologists but of all healthcare professionals. This is one of the most important messages found in advance of the new guidelines on anaphylaxis on which the European Academy of Allergy and Clinical Immunology (EAACI) is currently working.

    Read more here and the press release here.
  • More than 7% of the general population are affected by drug allergy reactions, involving excessive cost for the healthcare system

    Berne (Switzerland), April 14th 2014 – Drug Hypersensitivity Reactions (DHRs) affect 7% of the general population and represent a major health problem, as they can be life-threatening and require or prolong hospitalisation. Furthermore, both underdiagnosis (as they are insufficiently detected) and overdiagnosis (due to excessive use of the term “allergy”) are common in clinical practice, and this can lead to the prescription of more expensive or less effective drugs.

    To find out more, click here. Also available in French and German.
  • 9 out of 10 people die of a chronic disease in Europe

    EAACI was proud to join the European Chronic Disease Alliance (ECDA) at the first EU Summit on Chronic Diseases in Brussels from April 3-4. ECDA welcomed the Commission’s initiative to organise the Summit, which we hope to be a step towards an EU framework to allow the EU to make a significant impact in reaching the United Nations goal of a 25% reduction in premature mortality from chronic diseases by 2025.
  • Go Green with EAACI

    Reflecting the feedback from our recent Membership Benefits Survey we are asking you to "Go green with EAACI" and offering the possibility to opt out from receiving printed versions of Allergy and/or Pediatric Allergy and Immunology by selecting the opt out box(es) at the Membership Profile Management Page.